
|Videos|January 28, 2014
How Will Payers Manage Biosimilars?
Payers will encourage the use of biosimilars where appropriate through the use of step edits, lower tiers, and novel strategies, said Steven Lucio, Senior Director, Clinical Solutions and Pharmacy Program Development at Novation.
Advertisement
Payers will encourage the use of biosimilars where appropriate through the use of step edits, lower tiers, and novel strategies, said Steven Lucio, Senior Director, Clinical Solutions and Pharmacy Program Development at Novation.
This video was shot at the 2013 Academy of Managed Care Pharmacy in San Antonio, Texas.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Sonrotoclax Plus Zanubrutinib Produces Deep MRD Responses in Treatment-Naive CLL
2
Orforglipron Reduces Body Weight Up to 14% in Women at Every Stage of Menopause
3
"I Didn't Do This to Myself": How Mary Katherine Cheeley Uses Lp(a) Education to Transform Patient Adherence
4
Managing Grade 1 CRS in Patients With Follicular Lymphoma on Bispecific Antibodies: Home vs Health Care Facility Referred
5































































































































